Eversource-Wealth-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
4,128
Total Value
1630861225
Accession Number
0001710537-25-000003
Form Type
13F-HR
Manager Name
Eversource-Wealth-Advisors
Data Enrichment
82% identified
3,393 identified735 unidentified

Holdings

4,128 positions • $1.6B total value
Manager:
Search and click to pin securities to the top
Page 193 of 201
UNITED STATES LIME & MINERALS INC
Shares:—
Value:$88
% of Portfolio:0.0% ($88/$1.6B)
Southland Holdings, Inc.
Shares:—
Value:$87
% of Portfolio:0.0% ($87/$1.6B)
Forafric Global PLC
Shares:—
Value:$86
% of Portfolio:0.0% ($86/$1.6B)
Information Services Group Inc.
Shares:—
Value:$86
% of Portfolio:0.0% ($86/$1.6B)
Humacyte, Inc.
Shares:—
Value:$85
% of Portfolio:0.0% ($85/$1.6B)
WideOpenWest, Inc.
Shares:—
Value:$84
% of Portfolio:0.0% ($84/$1.6B)
GRAFTECH INTERNATIONAL LTD
Shares:—
Value:$84
% of Portfolio:0.0% ($84/$1.6B)
Inhibrx Biosciences, Inc.
Shares:—
Value:$84
% of Portfolio:0.0% ($84/$1.6B)
Tyra Biosciences, Inc.
Shares:—
Value:$84
% of Portfolio:0.0% ($84/$1.6B)
PLIANT THERAPEUTICS, INC.
Shares:—
Value:$84
% of Portfolio:0.0% ($84/$1.6B)
MACROGENICS INC
Shares:—
Value:$83
% of Portfolio:0.0% ($83/$1.6B)
COMPX INTERNATIONAL INC
Shares:—
Value:$83
% of Portfolio:0.0% ($83/$1.6B)
292812104
Shares:—
Value:$78
% of Portfolio:0.0% ($78/$1.6B)
Bank7 Corp.
Shares:—
Value:$77
% of Portfolio:0.0% ($77/$1.6B)
VALUE LINE INC
Shares:—
Value:$77
% of Portfolio:0.0% ($77/$1.6B)
008064107
Shares:—
Value:$75
% of Portfolio:0.0% ($75/$1.6B)
Regulus Therapeutics Inc.
Shares:—
Value:$74
% of Portfolio:0.0% ($74/$1.6B)
Offerpad Solutions Inc.
Shares:—
Value:$73
% of Portfolio:0.0% ($73/$1.6B)
PATHWARD FINANCIAL, INC.
Shares:—
Value:$73
% of Portfolio:0.0% ($73/$1.6B)
ORION ENERGY SYSTEMS, INC.
Shares:—
Value:$72
% of Portfolio:0.0% ($72/$1.6B)